To compare the effect of 2 drugs namely Prednisolone and Dexamethasone while treating newly diagnosed ITP and to see if there is any correlation with T regulatory cell levels
Not Applicable
- Conditions
- Health Condition 1: D693- Immune thrombocytopenic purpura
- Registration Number
- CTRI/2019/08/020501
- Lead Sponsor
- DrDebranjani Chattopadhyay
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of any age and of either gender who are newly diagnosed with immune thrombocytopenia as per the IWG guidelines and who are willing to give consent for the study
Exclusion Criteria
1.Patients with chronic or relapsed or refractory immune thrombocytopenia
2.Patients who have already received therapy in the form of prior steroid therapy or immunomodulators within 3 months of enrollment.
3.Immune thrombocytopenia associated with secondary causes viz HIV, HCV, & malignancies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding Scores <br/ ><br>Platelet count improvement <br/ ><br>Time to response <br/ ><br>Complications with treatmentTimepoint: Bleeding Scores <br/ ><br>Platelet count improvement <br/ ><br>Time to response <br/ ><br>Complications with treatment
- Secondary Outcome Measures
Name Time Method Correlation with T regulatory cell percentage level in either treatment arm.Timepoint: At the onset of the disease prior to starting therapy